Michele Cottler‐Fox
Professor
Also affiliated: University of Maryland, Baltimore (1996–2003); National Institutes of Health (1974–1998); Oregon State University (1974–1975); National Marrow Donor Program (1991); Georgetown University (1988–1992); University of Michigan (1998); NOAA Ocean Exploration (1988); University of Arkansas Medical Center (2016); Georgetown University Medical Center (1989–1991); Albert B. Chandler Hospital (1998); MedStar Georgetown University Hospital (1988); Karolinska Institutet (1979–1987); Arkansas Cardiology (2020); Dutch Blood Transfusion Society (1993); Central Arkansas Veterans Healthcare System (2006–2008); Foundation for Ichthyosis and Related Skin Types (1986); National Heart Lung and Blood Institute (1995–1997); National Institute of Neurological Disorders and Stroke (1995); Dana-Farber Cancer Institute (1998–2003); Ann Arbor VA Medical Center (1998); Winthrop Rockefeller Foundation (2017); National Cancer Institute (1997); National Institute of Allergy and Infectious Diseases (1975); National Cancer Institute (1974–1978); Vince Lombardi Cancer Clinic (1989–1990); National Institutes of Health Clinical Center (1992–1997); Arkansas Department of Agriculture (2016); U-M Rogel Cancer Center (1998–2001); University of Bergen (2013)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Michele Cottler‐Fox, a professor at the University of Arkansas for Medical Sciences, has a research focus that includes hematopoietic stem cell transplantation and multiple myeloma treatments. Her work has investigated long-term outcomes of various therapeutic regimens for multiple myeloma, such as maintenance therapy with VRD (bortezomib, lenalidomide, dexamethasone) and the impact of fractionated melphalan transplants with added bortezomib and thalidomide. Cottler‐Fox also examines operational aspects of cell therapy laboratories, including the effects of new collection goals on apheresis processes and the implications of autologous hematopoietic progenitor cell boosts after CAR-T therapy.
Her research extends to cord blood banking, exploring the barriers and facilitators among pregnant women, including specific investigations into Hispanic populations. Additionally, Cottler‐Fox has contributed to understanding thrombotic microangiopathies, identifying predictors of acquired thrombotic thrombocytopenic purpura (aTTP) using HLA-DR-DQ associations and the PLASMIC score. She leads a research group and collaborates with colleagues at the University of Arkansas for Medical Sciences, including Clyde Bailey and Susan Panozzo. Cottler‐Fox is recognized as a highly cited researcher, with an h-index of 42 and over 200 publications.
Metrics
- h-index: 42
- Publications: 209
- Citations: 6,695
Selected Publications
-
Post‐transport macroscopic aggregates in a filtered bone marrow harvest bag (2026)
-
Barriers and facilitators to, and knowledge of, cord blood banking among pregnant Hispanic women at a university obstetric clinic (2026)
-
Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services (2025)
-
AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY (2025)
-
SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB (2024)
-
HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies (2024)
-
Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up (2023)
-
Barriers and facilitators to cord blood banking among pregnant women at a university obstetric clinic (2023)
-
Hybrid cord blood banks may be advantageous for scientific as well as economic reasons (2020)
-
Concepts and Rationale for Using Predictive Algorithms for Hematopoietic Progenitor Cell Apheresis Collection (2019)
-
A hands‐on resident umbilical cord blood educational curriculum compared to online education of post‐residency obstetricians: comparison of the volume of collected cord blood units (2019)
-
ADAMTS13 Testing Methodologies and Thrombotic Thrombocytopenic Purpura (TTP): Conflicting Results Can Pose a Clinical Dilemma. (2018)
-
M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion (2018)
-
Optia® continuous mononuclear collection (CMNC) system is a safe and efficient system for hematopoietic progenitor cells‐apheresis (HPC‐a) collection and yields a lower product hematocrit (HCT%) than the COBE® spectra system: A retrospective study (2018)
-
Complement Regulatory Genetic Mutations in the Setting of Autoimmune Thrombotic Thrombocytopenic Purpura: A Case Series (2017)
Collaboration Network
Top Collaborators
- SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- Barriers and facilitators to cord blood banking among pregnant women at a university obstetric clinic
- Barriers and facilitators to, and knowledge of, cord blood banking among pregnant Hispanic women at a university obstetric clinic
- Barriers and facilitators to cord blood banking among pregnant women at a university obstetric clinic
- Barriers and facilitators to, and knowledge of, cord blood banking among pregnant Hispanic women at a university obstetric clinic
- Barriers and facilitators to cord blood banking among pregnant women at a university obstetric clinic
- Barriers and facilitators to, and knowledge of, cord blood banking among pregnant Hispanic women at a university obstetric clinic
- HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies
- Barriers and facilitators to, and knowledge of, cord blood banking among pregnant Hispanic women at a university obstetric clinic
- SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- Barriers and facilitators to cord blood banking among pregnant women at a university obstetric clinic
- Barriers and facilitators to cord blood banking among pregnant women at a university obstetric clinic
- Barriers and facilitators to cord blood banking among pregnant women at a university obstetric clinic
- Barriers and facilitators to cord blood banking among pregnant women at a university obstetric clinic
- Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up
- Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up
- Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up
Similar Researchers
Based on overlapping research topics